Work

RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine

Year: 2023

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2023.11.037

Authors: Yuanyuan Wang, Yunqi Hu, Yong Ma, Pengbin Li, Siwei Zhou, Mengxin Xu, Bing He, Shuning Liu, Kexin Lv, Sizhe Liu, Yu Zhang, Na Zhou, Shifeng Chen, Feng Ye, Yao-Qing Chen

Institution: Sun Yat-sen University

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Science, Technology and Innovation Commission of Shenzhen Municipality, National Key Research and Development Program of China

Awards: G2520461146, G330774179, G3350184516, G5666395957, G7023982736

OpenAlex ID: W4389047828

FWCI: 0.206

Cites: 17

Cited by: 1

Related to: 10